Maven Securities LTD Pfizer Inc Transaction History

Maven Securities LTD

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$25.89 - $29.73 $646,576 - $742,477	24,974 Added 158.83%	40,698 $1.13 Million
Q4 2023 Feb 12, 2024	BUY	$26.13 - $33.94 $199,058 - $258,554	7,618 Added 93.98%	15,724 $452,000
Q3 2023 Nov 13, 2023	SELL	$32.09 - $37.51 $887,384 - $1.04 Million	-27,653 Reduced 77.33%	8,106 $268,000
Q2 2023 Aug 04, 2023	BUY	$36.12 - $41.79 $1.29 Million - $1.49 Million	35,759 New	35,759 $1.31 Million
Q4 2022 Feb 14, 2023	SELL	$41.75 - $54.5 $1.02 Million - $1.33 Million	-24,329 Reduced 71.17%	9,857 $505,000
Q3 2022 Nov 14, 2022	BUY	$43.76 - $53.42 $1.15 Million - $1.4 Million	26,265 Added 331.59%	34,186 $15 Million
Q2 2022 Aug 15, 2022	BUY	$46.53 - $55.17 $368,564 - $437,001	7,921 New	7,921 $415,000
Q4 2021 Feb 14, 2022	SELL	$41.32 - $61.25 $324,651 - $481,241	-7,857 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$39.25 - $50.42 $656,809 - $843,728	-16,734 Reduced 68.05%	7,857 $338,000
Q2 2021 Aug 16, 2021	BUY	$35.91 - $40.68 $676,616 - $766,492	18,842 Added 327.74%	24,591 $963,000
Q1 2021 May 17, 2021	BUY	$33.49 - $37.77 $192,534 - $217,139	5,749 New	5,749 $209,000
Q4 2020 Feb 12, 2021	SELL	$33.47 - $42.56 $242,858 - $308,815	-7,256 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$31.75 - $37.25 $48,006 - $56,322	-1,512 Reduced 17.24%	7,256 $265,000
Q2 2020 Aug 14, 2020	SELL	$30.12 - $36.54 $144,425 - $175,209	-4,795 Reduced 35.35%	8,768 $284,000
Q1 2020 May 15, 2020	BUY	$27.03 - $38.62 $366,607 - $523,803	13,563 New	13,563 $443,000

3,220

3.71B

73.2M

108M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $163B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Maven Securities LTD, based on Form 13F filings with the SEC.

Stay updated on Maven Securities LTD with notifications on news.